Treatment-resistant lymphomas 'reprogrammed' to respond to cancer drugs

A phase I clinical trial showed diffuse, large B-cell lymphomas resistant to chemotherapy can be reprogrammed to respond to treatment using the drug azacitidine, according to a study published in Cancer Discovery , a journal of the American Association for Cancer Research.

http://www.medicalnewstoday.com/releases/264978.php